Valuation check: ALHC's P/E ratio is 65.96, above the Finance sector average of 16.59.
Get informed when a big investor buys or sells
+ Follow65.96
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Alignment Healthcare (ALHC) currently reports a P/E ratio of 65.96. That is above the Finance sector average of 16.59. Use the charts on this page to explore Alignment Healthcare's P/E ratio history and peer comparisons.
Alignment Healthcare's P/E ratio of 65.96 is higher than the Finance sector average of 16.59. That is roughly 297.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Alignment Healthcare's market price to a fundamental measure such as earnings, sales, or book value. At 65.96, ALHC can look expensive or cheap only in context — versus its own history, growth rate, and Finance peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 65.96, then check the historical chart for trend and the peer comparison chart for relative positioning. The Finance average is 16.59. From there, open related valuation or income-statement pages for Alignment Healthcare, and consider following ALHC for alerts when major investors trade the stock.
Alignment Healthcare is classified in the Finance sector. On P/E ratio, it currently shows 65.96 versus a sector average near 16.59. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Finance are usually more informative than comparing ALHC with unrelated industries.